All G Email Format
Biotechnology ResearchNew South Wales, Australia11-50 Employees
All G, based in Sydney, New South Wales, Australia, develops high-value milk proteins for nutrition through precision fermentation. It currently centers on bovine lactoferrin and aims to build a pipeline of human milk proteins to improve infant formula toward closer resemblance to human milk. The company operates in the biotechnology research sector and is a smaller, early-stage player focused on dairy-protein production. A recent development is a joint venture with Armor Protéines to produce and commercialize human and bovine lactoferrin. All G has signaled the planned launch of its recombinant bovine lactoferrin in early 2026, reflecting its progress toward product commercialization.